Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature

American Journal of Public Health

Volumn 105, Issue 11, 2015, Pages e29-e49

  Martins, Silvia S ^a   Sampson, Laura ^b   Cerdá, Magdalena ^c   Galea, Sandro ^b  

^a Department of Medicine   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG; STREET DRUG;

ACCIDENT; DRUG OVERDOSE; EPIDEMIC; HEALTH; HUMAN; MORTALITY; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ACCIDENTS; ANALGESICS, OPIOID; DRUG OVERDOSE; EPIDEMICS; GLOBAL HEALTH; HUMANS; PRESCRIPTION DRUGS; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; SOCIOECONOMIC FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84943781703     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2015.302843     Document Type: Review

References (169)

1. Paulozzi LJ. Overdoses are injuries too. Inj Prev. 2007;13(5):293-294.
2. Cerdá M, Ransome Y, Keyes KM, et al. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132(1-2):53-62.
3. Centers for Disease Control and Prevention. Wide-Ranging Online Data for Epidemiologic Research (WONDER). 2010. Available at: http://wonder. cdc. gov. Accessed September 27, 2011.
4. International Overdose Awareness Day. Overdose: worse than the road toll. Available at: http://www. overdoseday. com/wp-content/uploads/2013/07/ Factsheet-Greater-than-the-Road-Toll-KE-FINAL-15-August-2013. pdf. Accessed August 14, 2015.
5. 2012 annual report on the state of the drugs problem in Europe. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2012.
6. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR Morbid Mortal Wkly Rep. 2013;62(26):537-542.
7. Centers for Disease Control and Prevention. Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR Morb Mortal Wkly Rep. 2009;58 (42):1171-1175.
8. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. 2011;60(43): 1487-1492.
9. Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J Urban Health. 2007;84(2):283-291.
10. Schweitzer VG, Darrat I, Stach BA, Gray E. Sudden bilateral sensorineural hearing loss following polysubstance narcotic overdose. J Am Acad Audiol. 2011;22(4):208-214.
11. White AM, Hingson RW, Pan IJ, Yi HY. Hospitalizations for alcohol and drug overdoses in young adults ages 18-24 in the United States, 1999-2008: results from the Nationwide Inpatient Sample. J Stud Alcohol Drugs. 2011;72(5):774-786.
12. McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction. 1998;93(5):701-711.
13. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26(3):453-460.
14. Bohnert AS, Tracy M, Galea S. Characteristics of drug users who witness many overdoses: implications for overdose prevention. Drug Alcohol Depend. 2012;120(1-3):168-173.
15. Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14 (7):616-623.
16. Tracy M, Piper TM, Ompad D, et al. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005;79(2):181-190.
17. Bohnert AS, Tracy M, Galea S. Circumstances and witness characteristics associated with overdose fatality. Ann Emerg Med. 2009;54(4):618-624.
18. Centers for Disease Control and Prevention. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(6):101-105.
19. Fairbairn N, Wood E, Stoltz JA, Li K, Montaner J, Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health. 2008;122(1):70-78.
20. Bohnert AS, Nandi A, Tracy M, et al. Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend. 2011;113(1):62-68.
21. Gutiérrez-Cebollada J, de la Torre R, Ortuño J, Garcés J, Camí J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend. 1994;35(2): 169-174.
22. Galea S, Ahern J, Tardiff K, et al. Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J Urban Health. 2003;80(2):201-211.
23. Zimmerman JL. Cocaine intoxication. Crit Care Clin. 2012;28(4):517-526.
24. Vormfelde SV, Poser W. Death attributed to methadone. Pharmacopsychiatry. 2001;34(6):217-222.
25. Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1): 32-51.
26. Paulozzi LJ. Prescription drug overdoses: A review. J Safety Res. 2012;43(4): 283-289.
27. Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: A systematic review and meta-analysis. Bull World Health Organ. 2013;91(2): 102-123.
28. Lanier WA, Johnson EM, Rolfs RT, Friedrichs MD, Grey TC. Risk factors for prescription opioid-related death, Utah, 2008-2009. Pain Med. 2012;13(12): 1580-1589.
29. Bohnert AS, Roeder K, Ilgen MA. Unintentional overdose and suicide among substance users: A review of overlap and risk factors. Drug Alcohol Depend. 2010;110(3):183-192.
30. Merrall EL, Kariminia A, Binswanger IA, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010;105(9):1545-1554.
31. PubMed. Bethesda, MD: US National Library of Medicine, National Institutes of Health.
32. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006;31(5):907-912.
33. Tobin KE, Davey MA, Latkin CA. Calling emergency medical services during drug overdose: An examination of individual, social and setting correlates. Addiction. 2005;100(3):397-404.
34. Werb D, Kerr T, Lai C, Montaner J, Wood E. Nonfatal overdose among a cohort of street-involved youth. J Adolesc Health. 2008;42(3):303-306.
35. Britton PC, Wines JD II, Conner KR. Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend. 2010;107(1):51-55.
36. Galea S, Nandi A, Coffin PO, et al. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006;25(3):79-87.
37. Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J SubstAbuse Treat. 2006;30(2):129-133.
38. Bradvik L, Frank A, Hulenvik P, Medvedeo A, Berglund M. Heroin addicts reporting previous heroin overdoses also report suicide attempts. Suicide Life Threat Behav. 2007;37(4):475-481.
39. Baca CT, Grant KJ. What heroin users tell us about overdose. J Addict Dis. 2007;26(4):63-68.
40. Cullen W, Bury G, Langton D. Experience of heroin overdose among drug users attending general practice. Br J Gen Pract. 2000;50(456):546-549.
41. Darke S, Mills KL, Ross J, Teesson M. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug Alcohol Depend. 2011;115(3):190-195.
42. Darke S, Sunjic S, Zador D, Prolov T. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 1997;47(1):45-53.
43. Kerr D, Dietze P, Kelly AM, Jolley D. Improved response by peers after witnessed heroin overdose in Melbourne. Drug Alcohol Rev. 2009;28(3):327-330.
44. Kerr D, Dietze P, Kelly AM, Jolley D. Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration. J Urban Health. 2008;85(3): 352-360.
45. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction. 1996;91(3):413-417.
46. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91(3):405-411.
47. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313(7054):402.
48. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health. 2001;91(11):1842-1846.
49. Taylor A, Frischer M, Goldberg D. Non-fatal overdosing is related to polydrug use in Glasgow. BMJ. 1996; 313(7069):1400-1401.
50. Bluthenthal RN, Kral AH, Lorvick J, Erringer EA, Edlin BR. Harm reduction and needle exchange programmes. Lancet. 1998;351(9118):1819-1820.
51. Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health. 2005;82(2):303-311.
52. Jenkins LM, Banta-Green CJ, Maynard C, et al. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health. 2011;88(1): 118-128.
53. Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large U. S. city. Drug Alcohol Depend. 2007;88(2-3):182-187.
54. Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. Am J Prev Med. 2006;31(3): 261-264.
55. Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21(3):186-193.
56. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: A 10-year follow-up of the UFO Study. Am J Epidemiol. 2012;175(4): 302-308.
57. Seal KH, Downing M, Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003;80(2):291-301.
58. Davidson PJ, Ochoa KC, Hahn JA, Evans JL, Moss AR. Witnessing heroinrelated overdoses: The experiences of young injectors in San Francisco. Addiction. 2002;97(12):1511-1516.
59. Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health. 2003;80(2):212-219.
60. Powis B, Strang J, Griffiths P, et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999;94(4): 471-478.
61. Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39-45.
62. Bennett GA, Higgins DS. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94(8): 1179-1189.
63. Bergenstrom A, Quan VM, Van Nam L, et al. A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among outof-treatment injecting drug users in North Vietnam. Subst Use Misuse. 2008;43(1): 73-84.
64. Havens JR, Oser CB, Knudsen HK, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011;115(1-2):107-112.
65. Fischer B, Brissette S, Brochu S, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ. 2004;171(3):235-239.
66. Fischer B, Manzoni P, Rehm J. Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort). Eur Addict Res. 2006;12(4):230-239.
67. Tobin KE, Latkin CA. The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. J Urban Health. 2003;80(2):220-229.
68. Man LH, Best D, Gossop M, Stillwell G, Strang J. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. Eur Addict Res. 2004;10(1):35-40.
69. Silva K, Schrager SM, Kecojevic A, Lankenau SE. Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend. 2013;128(1-2):104-110.
70. Kinner SA, Milloy M, Wood E, Qi J, Zhang R, Kerr T. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict Behav. 2012;37(6): 691-696.
71. Centers for Disease Control and Prevention. Unintentional and undetermined poisoning deaths-11 States, 1990-2001. MMWR Morbid Mortal Wkly Rep. 2004;53(11):233-238.
72. Paulozzi LJ, Annest JL. US data show sharply rising drug-induced death rates. Inj Prev. 2007;13(2):130-132.
73. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997-1005.
74. Degenhardt L, Day C, Dietze P, et al. Effects of a sustained heroin shortage in three Australian States. Addiction. 2005;100(7):908-920.
75. Edwards EM, Searles J, Shapiro S. Deaths involving drugs in Vermont, 2004 through 2010. Arch Intern Med. 2011;171(18):1676-1678.
76. Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: A description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009;18(1):5-14.
77. Hammersley R, Cassidy M, Oliver J, Hammersley R, Cassidy MT, Oliver J. Drugs associated with drug-related deaths in Edinburgh and Glasgow, November 1990 to October 1992. Addiction. 1995;90(7):959-965.
78. Shah NG, Lathrop SL, Reichard RR, Landen MG. Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction. 2008;103(1):126-136.
79. Mueller MR, Shah NG, Landen MG. Unintentional prescription drug overdose deaths in New Mexico, 1994-2003. Am J Prev Med. 2006;30(5):423-429.
80. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618-627.
81. Fingerhut L. Increases in poisoning and methadone-related deaths: United States, 1999-2005. Centers for Disease Control and Prevention. 2008. Available at: http://www. cdc. gov/nchs/data/ hestat/poisoning/poisoning. pdf. Accessed August 14, 2015.
82. Centers for Disease Control and Prevention. Drug overdose deaths-Florida, 2003-2009. MMWR Morb Mortal Wkly Rep. 2011;60(26):869-872.
83. Madden ME, Shapiro SL. The methadone epidemic: methadone-related deaths on the rise in Vermont. Am J Forensic Med Pathol. 2011;32(2):131-135.
84. Socie E, Hirsch A, Beeghly CB, Ohio Department of Health, Centers for Disease Control and Prevention. The Burden of Poisoning in Ohio, 1999-2008. Columbus, OH: Violence and Injury Prevention Program, Ohio Department of Health; 2010.
85. Wells C. Report: Deaths related to drug poisoning in England and Wales, 2008. Health Stat Q. 2009;(43):48-55.
86. Wisniewski AM, Purdy C, Blondell R. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis. 2008;27(1):1-11.
87. Centers for Disease Control and Prevention. Vital signs: risk for overdose from methadone used for pain relief- United States, 1999-2010. MMWR Morbid Mortal Wkly Rep. 2012;61 (26):493-497.
88. Hawton K, Bergen H, Simkin S, Wells C, Kapur N, Gunnell D. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study. PLoS Med. 2012;9(5):e1001213.
89. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. HHS publication no. (SMA) 13-4760, DAWN Series D-39.
90. Green TC, Grau LE, Carver H, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend. 2011;115(3): 221-228.
91. Degenhardt LJ, Conroy E, Gilmour S, Hall W. The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New SouthWales, Australia. Med J Aust. 2005;182(1):20-23.
92. Calcaterra S, Glanz J, Binswanger I. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013;131(3):263-270.
93. Cochella S, Bateman K. Provider detailing: An intervention to decrease prescription opioid deaths in Utah. Pain Med. 2011; 12(suppl 2):S73-S76.
94. Johnson EM, Porucznik C, Anderson J, Rolfs R. State-level strategies for reducing prescription drug overdose deaths: Utah's prescription safety program. Pain Med. 2011;12(suppl 2):S66-S72.
95. Scott G, Thomas SD, Pollack HA, Ray B. Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. J Urban Health. 2007;84(2):292-306.
96. Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. Lancet. 2011; 377(9775):1429-1437.
97. Wood E, Stoltz JA, Li K, Montaner JS, Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction. 2006;101(5): 689-695.
98. Friedman LS. Real-time surveillance of illicit drug overdoses using poison center data. Clin Toxicol (Phila). 2009;47(6): 573-579.
99. Schwartz RP, Gryczynski J, O'Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health. 2013;103(5):917-922.
100. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89-96.
101. Neeleman J, Farrell M. Fatal methadone and heroin overdoses: time trends in England and Wales. J Epidemiol Community Health. 1997;51(4):435-437.
102. Duncan DF. Drug law enforcement expenditures and drug-induced deaths. Psychol Rep. 1994;75(1 pt 1):57-58.
103. Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief. 2011;81(22):1-8.
104. Merrall EL, Bird SM, Hutchinson SJ. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study. Int J Drug Policy. 2012;23(1):24-32.
105. Shah NG, Lathrop SL, Flores JE, Landen MG. The influence of living along the U. S.-Mexico border on unintentional drug overdose death, New Mexico (USA), 2005-2009. Drug Alcohol Depend. 2012;125(1-2):19-26.
106. Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction. 2008;103(2):251-255.
107. Marshall BD, Milloy M-J, Wood E, Galea S, Kerr T. Temporal and geographic shifts in urban and non-urban cocainerelated fatal overdoses in a Canadian setting. Ann Epidemiol. 2012;22(3):198-206.
108. Milloy MJ,Wood E, Reading C, Kane D, Montaner J, Kerr T. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: A population-based analysis. Addiction. 2010;105(11):1962-1970.
109. Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976-87. Public Health Rep. 1990;105(5):455-462.
110. Coffin PO, Galea S, Ahern K, Leon A, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction. 2003;98(6):739-747.
111. Torralba L, Brugal MT, Villalbi JR, Tortosa MT, Toribio A, Valverde JL. Mortality due to acute adverse drug reactions: opiates and cocaine in Barcelona, 1989-93. Addiction. 1996;91(3):419-426.
112. Marzuk PM, Tardiff K, Leon AC, et al. Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: An ecological study. Am J Drug Alcohol Abuse. 1997;23(2):221-228.
113. Tardiff K, Marzuk P, Leon A, et al. Accidental fatal drug overdoses in New York City: 1990-1992. Am J Drug Alcohol Abuse. 1996;22(2):135-146.
114. Stenbacka M, Leifman A, Romelsjo A. Mortality and cause of death among 1705 illicit drug users: A 37-year follow up. Drug Alcohol Rev. 2010;29(1):21-27.
115. Vlahov D, Wang C, Ompad D, et al. Mortality risk among recent-onset injection drug users in five U. S. cities. Subst Use Misuse. 2008;43(3-4):413-428.
116. Hickman M, Hope V, Coleman B, et al. Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. J Public Health (Oxf). 2009;31(3):374-382.
117. Manfredi R, Sabbatani S, Agostini D. Trend of mortality observed in a cohort of drug addicts of the metropolitan area of Bologna, North-Eastern Italy, during a 25-year-period. Coll Antropol. 2006;30(3): 479-488.
118. Miller CL, Kerr T, Strathdee SA, Li K, Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J. 2007;4:1.
119. Wang C, Vlahov D, Galai N, et al. The effect of HIV infection on overdose mortality. AIDS. 2005;19(9):935-942.
120. Brettle RP, Chiswick A, Bell J, et al. Pre-AIDS deaths in HIV infection related to intravenous drug use. QJM. 1997; 90(10):617-629.
121. Davidson PJ, McLean R, Kral A, Gleghorn A, Edlin B, Moss A. Fatal heroin-related overdose in San Francisco, 1997-2000: A case for targeted intervention. J Urban Health. 2003;80(2): 261-273.
122. Ruttenber AJ, Luke JL. Heroinrelated deaths: new epidemiologic insights. Science. 1984;226(4670):14-20.
123. Centers for Disease Control and Prevention. Vital signs: prescription painkiller overdoses: use and abuse of methadone as a painkiller. National Center for Injury Prevention and Control. 2012. Available at: http://www. cdc. gov/ VitalSigns/pdf/2012-07-vitalsigns. pdf. Accessed August 14, 2015.
124. Soyka M, Apelt S, Lieb M, Wittchen H. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: A nationally representative cohort study in 2694 patients. J Clin Psychopharmacol. 2006;26(6): 657-660.
125. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-2620.
126. Niveau G. Rougemont AL, La Harpe R. Methadone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983-1999. Eur J Public Health. 2002;12(3):224-227.
127. Albert S, Brason FW II, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(suppl 2):S77-S85.
128. Bird SM. Over 1200 drugs-related deaths and 190,000 opiate-users-years of follow-up: relative risks by sex and age group. Addict Res Theory. 2010;18:194-207.
129. Bargagli AM, Hickman M, Davoli M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health. 2006; 16(2):198-202.
130. Clausen T, Waal H, Thoresen M, Gossop M. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction. 2009;104(8): 1356-1362.
131. Shah R, Uren Z, Baker A, Majeed A. Trends in deaths from drug overdose and poisoning in England and Wales 1993-1998. J Public Health Med. 2001;23(3): 242-246.
132. Morgan O, Griffiths C, Baker A, Majeed A. Fatal toxicity of antidepressants in England and Wales, 1993-2002. Health Stat Q. 2004;(23):18-24.
133. Rocchi MB, Miotto P, Preti A. Distribution of deaths by unintentional illicit drug overdose in Italy based on periodicity over time, 1984-2000. Drug Alcohol Depend. 2003;72(1):23-31.
134. Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiol Drug Saf. 2013; 22(4):438-442.
135. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.
136. Krinsky CS, Lathrop SL, Crossey M, Baker G, Zumwalt R. A toxicology-based review of fentanyl-related deaths in New Mexico (1986-2007). Am J Forensic Med Pathol. 2011;32(4):347-351.
137. Boddiger D. Fentanyl-laced street drugs "kill hundreds. " Lancet. 2006; 368(9535):569-570.
138. Soloway RA. Street-smart advice on treating drug overdoses. Am J Nurs. 1993;93(9):65-72.
139. Cook S, Moeschler O, Michaud K, Yersin B. Acute opiate overdose: characteristics of 190 consecutive cases. Addiction. 1998;93(10):1559-1565.
140. New York City Department of Health and Mental Hygiene. Illicit drug use in New York City. NYC Vital Signs. 2010;9(1):1-4.
141. Andrews JY, Kinner SA. Understanding drug-related mortality in released prisoners: A review of national coronial records. BMC Public Health. 2012;12:270.
142. Clark MJ, Bates AC. Nonfatal heroin overdoses in Queensland, Australia: An analysis of ambulance data. J Urban Health. 2003;80(2):238-247.
143. Dietze P, Jolley D, Cvetkovski S. Patterns and characteristics of ambulance attendance at heroin overdose at a localarea level in Melbourne, Australia: implications for service provision. J Urban Health. 2003;80(2):248-260.
144. Degenhardt L, Hall W, Adelstein B. Ambulance calls to suspected overdoses: New South Wales patterns July 1997 to June 1999. Aust N Z J Public Health. 2001;25(5):447-450.
145. Nandi A, Galea S, Ahern J, Bucciarelli A, Vlahov D, Tardiff K. What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Soc Sci Med. 2006;63(3):662-674.
146. Cerdá M, Ransome Y, Keyes KM, et al. Revisiting the role of the urban environment in substance use: The case of analgesic overdose fatalities. Am J Public Health. 2013;103(12):2252-2260.
147. Gotsens M, Mari-Dell'Olmo M, Martinez-Beneito MA, et al. Socio-economic inequalities in mortality due to injuries in small areas of ten cities in Spain (MEDEA Project). Accid Anal Prev. 2011;43(5): 1802-1810.
148. Siegel S. Pavlovian conditioning and drug overdose: when tolerance fails. Addict Res Theory. 2001;9(5):503-513.
149. Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39(1):1-23.
150. Raofi S, Schappert S. Medication therapy in ambulatory medical care; United States, 2003-2004. Vital Health Stat. 2006;13(163):1-40.
151. Rustøen T, Wahl AK, Hanestad BR, Lerdal A, Paul S, Miaskowski C. Gender differences in chronic pain-findings from a population-based study of Norwegian adults. Pain Manag Nurs. 2004;5(3): 105-117.
152. Hunter J, Smith B, Gribbin M. Demographic variables and chronic pain. Clin J Pain. 2001;17(4 suppl):S14-S19.
153. Centers for Disease Control and Prevention. Prescription painkiller overdoses: A growing epidemic, especially among women. 2013. Available at: http://www. cdc. gov/vitalsigns/ PrescriptionPainkillerOverdoses/index. html. Accessed August 14, 2015.
154. Cheng M, Sauer B, Johnson E, Porucznik C, Hegmann K. Comparison of opioid-related deaths by work-related injury. Am J Ind Med. 2013;56(3):308-316.
155. Green TC, McGowan S, Yokell M, Pouget E, Rich J. HIV infection and risk of overdose: A systematic review and metaanalysis. AIDS. 2012;26(4):403-417.
156. Stewart LM, Henderson C, Hobbs M, Ridout S, Knuiman M. Risk of death in prisoners after release from jail. Aust N Z J Public Health. 2004;28(1):32-36.
157. Wines JD, Saitz R, Horton N, Lloyd-Travaglini C, Samet J. Overdose after detoxification: A prospective study. Drug Alcohol Depend. 2007;89(2-3):161-169.
158. Bohnert AS, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry. 2012; 169(1):64-70.
159. Ødegard E, Rossow I. Alcohol and non-fatal drug overdoses. Eur Addict Res. 2004;10(4):168-172.
160. Boyes AP. Repetition of overdose: A retrospective 5-year study. J Adv Nurs. 1994;20(3):462-468.
161. Volkow ND. Prescription opioid and heroin abuse: witness appearing before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations: Department of Health and Human Services, National Institutes of Health; April 29, 2014.
162. Logan J, Liu Y, Paulozzi L, Zhang K, Jones C. Opioid prescribing in emergency departments: The prevalence of potentially inappropriate prescribing and misuse. Med Care. 2013;51(8):646-653.
163. National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System: leading causes of death reports. 2008.
164. Shai D. Problems of accuracy in official statistics on drug-related deaths. Int J Addict. 1994;29(14):1801-1811.
165. Skopp G. Postmortem toxicology. Forensic Sci Med Pathol. 2010;6(4):314-325.
166. Pounder DJ, Fuke C, Cox DE, Smith D, Kuroda N. Postmortem diffusion of drugs from gastric residue: An experimental study. Am J Forensic Med Pathol. 1996;17(1):1-7.
167. Pounder DJ, Adams E, Fuke C, Langford A. Site to site variability of post-mortem drug concentration in liver and lung. J Forensic Sci. 1996;41(6):927-932.
168. Kostakis C, Byard R. Sudden death associated with intravenous injection of toad extract. Forensic Sci Int. 2009; 188(1-3):e1-e5.
169. Webster LR, Dasgupta N. Obtaining adequate data to determine causes of opioid-related overdose deaths. Pain Med. 2011;12(suppl 2):S86-S92.